BackAlexion Pharmaceuticals Overview

Alexion Pharmaceuticals EBIT

EBIT (Earnings Before Interest and Taxes) analysis for ALXN.

Quarterly EBIT

$825.90M
↑ 11.82% YoY

As of Mar 31, 2021

Annual EBIT (TTM)

$2.95B
↑ 23.76% YoY

Trailing 12 months ending Mar 31, 2021

Average EBIT (Comparison Companies)

EBIT History

EBIT Comparison

Annual EBIT Growth Rate (%)

Annual EBIT Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin